证券代码：300786 证券简称：国林科技 公告编号：2023-136 青岛国林科技集团股份有限公司 第四届董事会第二十五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或者重大遗漏。 一、董事会会议召开情况 青岛国林科技集团股份有限公司（以下简称"公司"）第四届董事会第二十 五次会议于2023年10月26日在公司会议室以现场结合通讯的方式召开。本次会议 通知已于2023年10月16日以邮件方式发出。本次会议应出席董事9人，实际出席 董事9人，董事张磊、王承宝、丁香军、徐洪魁以通讯方式参加，公司监事、部 分高级管理人员列席了本次会议，会议由董事长丁香鹏先生主持。本次会议的召 集、召开及审议程序符合《中华人民共和国公司法》（以下简称"《公司法》"）、 《青岛国林科技集团股份有限公司章程》（以下简称"《公司章程》"）以及有 关法律、法规的规定，会议决议合法有效。 具体内容详见同日刊载于巨潮资讯网的《青岛国林科技集团股份有限公司 2023年第三季度报告》（公告编号：2023-135）。 表决结果：9票同意，0票反对，0票弃权。 三、备查文件 二、董事会会议审议情况 ...

证券代码：300786 证券简称：国林科技 公告编号：2023-137 青岛国林科技集团股份有限公司（以下简称 "公司"）第四届监事会第二 十一次会议于2023年10月26日在公司会议室以现场结合通讯的方式召开。本次会 议通知已于2023年10月16日以邮件方式发出。本次会议应出席监事3名，实际出 席监事3名，监事丁金凤以通讯方式参加，董事会秘书兼副总经理胡文佳列席了 本次会议，会议由监事会主席段玮女士主持。本次会议的召集、召开及审议程序 符合《中华人民共和国公司法》（以下简称"《公司法》"）、《青岛国林科技 集团股份有限公司章程》（以下简称"《公司章程》"）以及有关法律、法规的 规定，会议决议合法有效。 二、监事会会议审议情况 经与会监事审议表决，形成如下决议： （一）审议通过《关于公司2023年第三季度报告的议案》 经审议，监事会认为：公司编制和审核《青岛国林科技集团股份有限公司2023 年第三季度报告》的程序符合法律、行政法规和中国证监会的规定，报告内容真 实、准确、完整地反映了上市公司的实际情况，不存在任何虚假记载、误导性陈 述或者重大遗漏。 具体内容详见同日刊载于巨潮资讯网的《青岛国林科技集团股份有 ...

证券代码：300786 证券简称：国林科技 公告编号：2023-133 青岛国林科技集团股份有限公司 关于取得专利证书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或者重大遗漏。 青岛国林科技集团股份有限公司（以下简称"公司"）于近日收到国家知识 产权局颁发的实用新型专利证书，具体情况如下： | 一种用于鼓风机的消 | 第19729538号 | ZL 2023 2 | 2023年2月27日 | 实用新型 | | --- | --- | --- | --- | --- | | 专利名称 音过滤装置 | 证书号 | 专利号 0322856.5 | 专利申请日期 | 专利类型 专利 | 本实用新型专利"一种用于鼓风机的消音过滤装置"，是一种新型高效、低 噪声的空气过滤器，采用内置活性炭、消音器相结合的一体化设计。该一体式结 构能够有效降低吸气口噪声，减少鼓风机吸入空气中所含的粉尘及杂质，清洁环 保，同时降低设备安装整体高度，对于后期设备维护提供了方便。目前该项专利 技术已应用于公司VPSA系统中鼓风机入口处过滤器，且已投入多个实际生产项 目使用，消音过滤效果良好。 上述 ...

Semiconductor Ozone Cleaning Equipment - Core components and most accessories of the semiconductor ozone cleaning equipment are independently developed, leveraging years of ozone industry expertise [1] - The company has a competitive advantage over other enterprises entering the semiconductor industry [1] - Products have been undergoing verification in semiconductor, panel, and scientific research industries since 2023, with plans for orderly production based on verification results [1] Glyoxylic Acid Products - Glyoxylic acid produced by the company uses ozone oxidation of maleic anhydride, free from carcinogenic glyoxal, making it highly competitive for downstream pharmaceutical, food additive, and cosmetic manufacturers [1][2] - Crystal glyoxylic acid has a concentration of over 98% for qualified products and over 98.5% for high-quality products, with lower formic acid and arsenic content compared to existing market products [2] - Crystal form is more convenient for transportation compared to aqueous solutions [2] - The company plans to focus on exporting crystal glyoxylic acid, with the remaining capacity for domestic sales of aqueous and crystal products [2] - The Xinjiang glyoxylic acid project's granulation and crystallization equipment is scheduled for no-load joint debugging by the end of September 2023, with production to follow [2] - Glyoxylic acid products have completed pilot tests in key application areas such as vanillin, pharmaceuticals, and chelated fertilizers, with ongoing market expansion based on existing orders [2] - The company adjusted the production process to produce granular glyoxylic acid crystals for easier use in customer production lines, with granulation crystallization being a physical reaction [2][3] Home Health Products - The company has developed a series of home health products, including ozone-activated carbon water purification systems, ultra-low temperature oxygen-rich atomizers, kitchen electrolyzed ozone water disinfectors, hydrogen-rich water machines, and medical oxygen concentrators [2] - Some products are already being sold online, and the medical oxygen concentrator has obtained medical device registration and completed relevant filing procedures [2] - The company plans to establish and improve the marketing and service network for health products, accelerate the cultivation of its own brand, and achieve rapid development in the health product sector [2]

证券代码：300786 证券简称：国林科技 公告编号：2023-131 青岛国林科技集团股份有限公司 2023 年第四次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 2、本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 （一）会议召开时间： 1、现场会议召开的时间：2023年9月13日（星期三）14:30。 2、网络投票时间：2023年9月13日，其中通过深圳证券交易所系统进行网络 投票的具体时间为2023年9月13日上午9:15-9:25，9:30-11:30，13:00-15:00；通过深 圳证券交易所互联网投票系统进行网络投票的具体时间为2023年9月13日 9:15-15:00期间的任意时间。 （二）股东大会召开的地点：山东省青岛市崂山区株洲路188号甲7楼会议室。 （三）会议召开方式：现场投票与网络投票相结合的方式。 （四）会议召集人：董事会。 （五）会议主持人：董事长丁香鹏先生。 特别提示： 1、本次股东大会没有出现否决议案情形； 本次股东大会采用现场投票和网络投票表决方式，审议通过了以下议案： （一 ...

法律意见书 德和衡证见意见(2023)第 200 号 北京德和衡律师事务所 www.deheng.com.cn 中国北京市朝阳区建国门外大街 2 号银泰中心 C 座 11、12 层 Tel：010-85407666 邮编：100022 北京德和衡律师事务所 关于青岛国林科技集团股份有限公司 2023年第四次临时股东大会的 北京德和衡律师事务所 关于青岛国林科技集团股份有限公司 2023年第四次临时股东大会的 法律意见书 德和衡证见意见(2023)第200号 致：青岛国林科技集团股份有限公司 北京德和衡律师事务所（以下简称"本所"）接受青岛国林科技集团股份有限公司（以下 简称"公司"）的委托，指派本所律师出席贵公司 2023 年第四次临时股东大会。本所律师依 据《中华人民共和国公司法》（以下简称"《公司法》"）、《上市公司股东大会规则》（以 下简称"《股东大会规则》"）、《青岛国林科技集团股份有限公司章程》（以下简称"《公 司章程》"）及相关法律法规，就本次股东大会的有关事宜出具本法律意见书。 本法律意见书仅就本次股东大会的召集和召开程序、会议召集人和出席会议人员的资格、 会议表决程序和表决结果的合法有效性等发 ...

证券代码：300786 证券简称：国林科技 公告编号：2023-130 在换届选举工作完成之前，公司第四届董事会和监事会全体成员、董事会各 专门委员会成员及高级管理人员将继续按照相关法律、法规和《公司章程》的有 关规定，履行相应的职责和义务。 公司董事会及监事会延期换届不会影响公司的正常运营。公司将积极推进董 事会、监事会的换届选举工作，并及时履行相应的信息披露义务。 特此公告。 青岛国林科技集团股份有限公司 董事会 2023年9月11日 青岛国林科技集团股份有限公司 关于董事会、监事会延期换届选举的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 青岛国林科技集团股份有限公司（以下简称"公司"）第四届董事会、监事 会将于2023年9月10日任期届满。鉴于新一届董事会、监事会换届工作尚在筹备 推进中，为保证公司董事会、监事会工作的连续性和稳定性，公司董事会、监事 会将延期换届选举，公司第四届董事会各专门委员会和高级管理人员的任期亦相 应顺延。 ...

证券代码：300786 证券简称：国林科技 青岛国林科技集团股份有限公司 投资者关系活动记录表 | --- | --- | --- | --- | |----------------|---------------|-------------|----------| | | | | 2023-011 | | | □特定对象调研 | □分析师会议 | | | 投资者关系活动 | □媒体采访 | □业绩说明会 | | 类别 □新闻发布会 路演活动 现场参观 其他（电话会议） 参与单位名称及 人员姓名 德邦证券股份有限公司 时间 2023 年 8 月 29 日 15:30-16:30 地点 公司会议室 上市公司接待人 董事会秘书兼副总经理：胡文佳女士 员姓名 证券事务专员：孙丽萍女士 本次投资者关系活动以电话会议的方式进行，公司相关 问题问答如下： 1、公司当前乙醛酸销售情况如何？ 报告期内，新疆子公司乙醛酸业务板块大概实现了 3000 多万的收入，其中包括乙醛酸水溶液、乙醛酸晶体及副产品甲 酸钾。乙醛酸水溶液是从今年五六月份开始对外销售，甲酸钾 投资者关系活动 基本在新疆当地能够消化完成，乙醛酸晶体的话基本是小批 ...

证券代码：300786 证券简称：国林科技 青岛国林科技集团股份有限公司 投资者关系活动记录表 | --- | --- | --- | --- | |----------------|---------------|-------------|----------| | | | | 2023-010 | | | □特定对象调研 | □分析师会议 | | | 投资者关系活动 | □媒体采访 | □业绩说明会 | | 类别 □新闻发布会 路演活动 现场参观 其他（电话会议） 参与单位名称及 人员姓名 东吴证券研究所 时间 2023 年 8 月 29 日 9:00-10:00 地点 公司会议室 上市公司接待人 董事会秘书兼副总经理：胡文佳女士 员姓名 证券事务专员：孙丽萍女士 本次投资者关系活动以电话会议的方式进行，公司相关 问题问答如下： 1.公司目前基本面情况介绍？ 公司专业从事臭氧产生机理研究、臭氧设备设计与制造、 臭氧应用工程方案设计与臭氧系统设备安装、调试、运营及维 护。公司现阶段的产品以大型臭氧发生器为主，涵盖全系列臭 投资者关系活动 氧发生器及臭氧系统的集成设备。公司在国内率先开发自来水 主要内容介绍 ...

Financial Performance - The company's operating revenue for the first half of 2023 was ¥135,926,258.52, representing a 7.42% increase compared to ¥126,535,869.93 in the same period last year[19]. - The net profit attributable to shareholders of the listed company was -¥6,493,576.57, a decrease of 177.82% from ¥8,344,485.89 in the previous year[19]. - The net cash flow from operating activities increased by 78.72% to ¥26,531,303.01, compared to ¥14,845,021.61 in the same period last year[19]. - The total assets at the end of the reporting period were ¥1,715,674,514.56, a slight increase of 0.48% from ¥1,707,444,341.21 at the end of the previous year[19]. - The net assets attributable to shareholders of the listed company decreased by 0.63% to ¥1,241,254,769.78 from ¥1,249,164,567.30 at the end of the previous year[19]. - Basic earnings per share were -¥0.04, down 180.00% from ¥0.05 in the same period last year[19]. - The diluted earnings per share were also -¥0.04, reflecting the same percentage decrease as basic earnings per share[19]. - The weighted average return on net assets was -0.52%, a decline of 1.26% compared to 0.74% in the previous year[19]. - The operating cost increased by 14.53% to ¥93,176,762.17 from ¥81,355,581.95, indicating rising production expenses[61]. - The company's net profit for the first half of 2023 was a loss of CNY 6,799,977.37, compared to a profit of CNY 8,270,911.61 in the first half of 2022[173]. Research and Development - The company is focusing on continuous R&D investment to drive technological upgrades and explore new applications for ozone technology in various industries[32]. - The company has developed a new electrolytic water-type ozone generator suitable for medical treatment and household water treatment, with mass production and market promotion expected in the second half of the year[29]. - The company has successfully developed an electrolytic water-type ozone generator, with plans for mass production and market promotion in the second half of the year[40]. - The company has mastered the core technology for producing crystalline glyoxylic acid using the ozone oxidation method, which has been included in the National "Industrial Foundation Innovation Development Catalog (2021 Edition)"[41]. - The company is focusing on the research and development of semiconductor-grade ultra-pure materials to reduce dependency on imports from the US, Japan, and South Korea[48]. - The company has invested significantly in R&D to maintain its technological edge, holding 59 patents and proprietary technologies in ozone generator manufacturing[89]. Market Expansion and Product Development - The company is actively expanding the application fields of glyoxylic acid products to capture high-end market opportunities, thereby enhancing profitability and risk resistance[42]. - The company is in the process of trial production for a 25,000 tons/year high-quality crystalline acetaldehyde project, which is expected to enhance sales revenue from acetaldehyde and its by-product potassium formate[27]. - The company has developed various ozone generation units and systems, including a flat-panel ozone generator and methods for recycling oxygen, showcasing its diverse product offerings[43]. - The company is focused on expanding its market presence through continuous research and development efforts in ozone technology[43]. - The company is developing a super-large ozone generator with a target output of 500 kg/h, which, upon completion, will be the highest capacity ozone generator in the world[47]. - The company has successfully completed the design and optimization phase for a catalytic oxidation test device, which can conduct various process combination tests[48]. Financial Management and Fundraising - The total amount of raised funds is CNY 65,923.69 million, with CNY 2,041.68 million invested during the reporting period[70]. - The cumulative amount of raised funds invested to date is CNY 52,612.1 million, representing 79.91% of the total raised funds[70]. - The company has not changed the use of raised funds, maintaining a 0.00% change ratio[70]. - The company has not reported any changes in fundraising projects during the reporting period[74]. - The company has not engaged in any derivative investments or entrusted loans during the reporting period[78]. - The company has not sold any significant assets or equity during the reporting period[79]. Corporate Governance and Shareholder Information - The major shareholder holds 28.73% of the company's shares, which could lead to risks associated with concentrated control over company decisions[92]. - The company has a policy that allows executives to transfer no more than 25% of their directly or indirectly held shares each year after leaving the company[148]. - The total number of ordinary shareholders at the end of the reporting period is 12,269[150]. - The largest shareholder, Dingxiangpeng, holds 28.73% of the shares, totaling 52,870,280 shares, with a decrease of 5,000 shares during the reporting period[150]. - The company emphasizes the importance of investor protection and has been optimizing the long-term mechanism for investor returns[111]. Environmental and Social Responsibility - The company has not faced any administrative penalties for environmental issues during the reporting period and is not classified as a key pollutant discharge unit[110]. - The company is committed to social responsibility, focusing on shareholder returns, customer service, employee development, and environmental sustainability[115]. - The company has implemented measures to reduce carbon emissions, although specific details were not disclosed[110]. Legal and Compliance - There were no significant lawsuits or arbitration matters during the reporting period, with a notable case involving a claim of approximately $46 million related to equipment defects still in progress[124]. - The company has not engaged in any major related party transactions or non-operating fund occupation by controlling shareholders during the reporting period[119][125]. - The company has not reported any major guarantees or leasing situations during the reporting period[136].